Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

NCT00722332 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Liver Transplantation

Interventions

BIOLOGICAL: HepaGam B

Sponsor

Cangene Corporation